Plus, news about Cyclacel Pharmaceuticals, MediciNova and Revolution Medicines:
Teva will divest its Japan business venture to private equity firm: The company
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.